The Pharmaceutical industry, also known as the pharma industry, is a highly regulated sector responsible for the research, development, and production of drugs and other health-related products. Pharma plays a vital role in improving public health and advancing medical science; thus, companies in the pharma sector must comply with laws and regulations that guarantee the safety and efficacy of their products, as well as laws regarding the approval and marketing of drugs, and those for the protection of their intellectual property.
Common legal issues in the pharma sector include patent and trademark litigation, regulatory compliance and product liability. As a consequence, pharma companies must navigate complex and rapidly changing regulations, including those related to clinical trials, drug approvals, and advertising.
Oppenheim provides pharma companies with legal advice and representation on a wide range of issues, including regulatory compliance, intellectual property protection, and litigation. Additionally, Oppenheim helps these companies navigate the complex legal landscape to identify and mitigate legal risks, allowing them to focus on their core mission of improving public health and advancing medical science.
Overall, Oppenheim plays a critical role in helping pharmaceutical companies navigate the complex legal landscape and succeed in this highly regulated and competitive industry.
Companies in this sector have engaged Oppenheim in a variety of issues, such as advising on the Hungarian aspects of the provision of investigational medicines on a compassionate use basis; as well as on various regulatory, licensing, contracting, pricing, marketing authorization and compliance matters. Additionally, our team has helped conduct a mock-down raid regarding compliance with drug promotional regulatory requirements.